Advanced Viral Research CP (ADVR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Advanced Viral Research CP (ADVR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: garden_man who wrote (1880)	12/15/1996 10:00:00 PM
From: garden_man	of 2281

To All: This may be of interest to the folks on this thread. I found the following information at the site listed below. critpath.org Reticulose--Treatment IND (applied for): For antiviral use against viral hepatitis, viral pneumonia, mumps, encephalitis, and influenza A. Some anti-HIV activity has been reported atspecific dilution levels, non-cytotoxic and no reported side effects. Delay in application due to amendment to obtain approval to commence human clinical trials with HIV-positive patients.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next